Skip to main content
Complete Genomics logo

Complete Genomics

2.7

A Complete Genomics Company

www.completegenomics.com
Location
San Jose, CA
Size
201-500 employees
Revenue
Unknown / Non-Applicable
Industry
Biotechnology Research
Founded
2005

Pioneering Genomic Sequencing Innovation

Complete Genomics stands at the forefront of biotechnology research, driving genomic breakthroughs that improve lives worldwide. Founded in 2005 and headquartered in San Jose, California, this privately held life sciences company has spent nearly two decades developing cutting-edge high-throughput sequencing technology. With 201-500 employees, Complete Genomics combines scientific excellence with customer-focused innovation to advance healthcare solutions globally.

Comprehensive End To End Genomic Solutions

As a global leader in next-generation sequencing (NGS), Complete Genomics offers a complete product portfolio spanning the entire genomic workflow:

  • Sample extraction and library preparation systems
  • Advanced lab automation equipment
  • DNBSEQ sequencing instruments ranging from low to extra-high throughput
  • Sophisticated data analysis platforms
  • Full-spectrum genetic sequencing instruments accelerating scientific breakthroughs

Innovation Driven Work Environment

Complete Genomics fosters a proactive, problem-solving culture where collaborative cross-functional teams tackle emerging challenges in genomics. Employees work in a customer-focused environment emphasizing empathy, service excellence, and scientific rigor. The company's San Jose demonstration laboratory serves as both an innovation hub and customer experience center, where team members showcase advanced technologies while building trusted partnerships with researchers.

Career Growth and Professional Development

The organization invests in employee success through:

  • Hands-on training in cutting-edge sequencing and analysis tools
  • Professional development opportunities in emerging biotechnology fields
  • Flexible work arrangements combining on-site collaboration and remote flexibility
  • Travel opportunities for conferences, customer sites, and scientific presentations
  • Dynamic team environments supporting continuous learning

Competitive Benefits and Work Life Balance

Complete Genomics demonstrates commitment to employee wellness through comprehensive benefits including medical, dental, and vision coverage, 401(k) retirement plans, and unique perks like gym membership reimbursements and employee discount programs. Team members enjoy 20 PTO days, 11 holidays annually, and education assistance programs supporting long-term career development in the rapidly evolving genomics industry.

Mission

To develop and promote advanced life science tools for future healthcare.

Frequently Asked Questions

Complete Genomics has 201-500 employees working across its San Jose headquarters and operations, collaborating on cutting-edge genomic sequencing technology and life science solutions.

Offices

Loading map...

Complete Genomics Highlights New Products, Partnerships, First DNBSEQ User Group Meeting at ASHG 2025

BOSTON, Oct. 14, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, today announced a series of milestones at the American Society of Human Genetics (ASHG) Annual Meeting, Oct. 14-18, 2025 in Boston. At ASHG 2025, for the first time, Complete Genomics will host a DNBSEQ(TM) User Group Meeting to bring together researchers and customers to share best practices, explore applications across oncology, rare disease and population genomics, and hear updates from the...

Read Full Article

Complete Genomics announces Gene by Gene as its newest sequencing service provider at ASHG

BOSTON, Oct. 13, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, today announced at the American Society of Human Genetics Annual Meeting that it has added Houston-based Gene by Gene, a leading genetics laboratory, to its Sequencing Service Provider Program. The Complete Genomics Service Provider Program connects its customers to a network of service providers, offering access to high-quality sequencing services using Complete Genomics DNBSEQ(TM) sequencing...

Read Full Article

Complete Genomics, Velsera partner to integrate sequencing and analysis platforms

CHICAGO, April 28, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing announced a collaboration with Velsera, a leading global healthcare technology company, to deliver an end-to-end genetic testing solution that integrates DNBSEQ(TM) sequencing technology with Velsera's Clinical Genomics Workspace (CGW) data analysis solution. The partnership, announced this week at the American Association for Cancer Research (AACR) Annual Meeting in Chicago, will accelerate...

Read Full Article

Complete Genomics Names Four Winners of Spatial Xcellerator Grant Program

SAN JOSE, Calif., April 15, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, today announced four winners from 30 applicants to its Spatial Xcellerator Grant Program. Winning projects address oncology, pediatric brain tumors, spinal cord injury and Alzheimer's disease. As the exclusive U.S. distributor of STOmics' Stereo-seq technology for spatial transcriptomics, Complete Genomics launched the Spatial Xcellerator Grant Program and spatial certified service...

Read Full Article

In 2024, Complete Genomics expanded U.S. manufacturing and technology capabilities toward a diversified, reliable supply chain for its flexible and cost-effective NGS solutions

SAN JOSE, Calif., Jan. 9, 2025 /PRNewswire/ -- In 2024, Complete Genomics, a pioneering genomic sequencing company, expanded its U.S. manufacturing footprint with augmented technology capabilities to diversify its supply chain helping it to continue reliably serving customers with flexible, cost-effective next generation sequencing (NGS) solutions. Expanding U.S. manufacturing capabilities in 2024 and beyond After weathering a year of geopolitical conflict which resulted in the failure of the...

Read Full Article